A pri-miR-218 variant and risk of cervical carcinoma in Chinese women

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Shi, Ting Yan ^a,b   Chen, Xiao Jun ^a,b   Zhu, Mei Ling ^a,b   Wang, Meng Yun ^a,b   He, Jing ^a,b   Yu, Ke Da ^a,b   Shao, Zhi Ming ^a,b   Sun, Meng Hong ^a,b   Zhou, Xiao Yan ^a,b   Cheng, Xi ^a,b   Wu, Xiaohua ^a,b   Wei, Qingyi ^a,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Case control study; Cervical cancer; Genetic susceptibility; LAMB3 miR 218 pathway; Polymorphism

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BINDING SITE; BODY MASS; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIFACTOR DIMENSIONALITY REDUCTION; PARITY; PREDICTION; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; UTERINE CERVICAL NEOPLASMS;

EID: 84872139409     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-19     Document Type: Article

References (34)

1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20. 10.1016/j.cell.2004.12.035, 15652477.
2. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309(5740):1519-1524. 10.1126/science.1111444, 16141061.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
4. Liu Z, Wei S, Ma H, Zhao M, Myers JN, Weber RS, Sturgis EM, Wei Q. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2011, 32(11):1668-1674. 10.1093/carcin/bgr209, 3204352, 21934093.
5. Chen AX, Yu KD, Fan L, Li JY, Yang C, Huang AJ, Shao ZM. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 2011, 7(9):e1002259. 10.1371/journal.pgen.1002259, 3164678, 21912531.
6. Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, Pan L, Shen H, Li Y, Hu Z. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol 2010, 117(2):287-290. 10.1016/j.ygyno.2010.01.020, 20163849.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
8. Tjalma WAA, Van Waes TR, Van den Eeden LEM, Bogers JJPM. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Practice; Res Clinical Obstetrics; Gynaecol 2005, 19(4):469-483. 10.1016/j.bpobgyn.2005.02.002, 23447450.
9. Green J, Berrington De Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, Deacon J, Hermon C, Jha P, Mant D. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-control Study of Cervical Cancer. Br J Cancer 2003, 89(11):2078-2086. 10.1038/sj.bjc.6601296, 2376844, 14647141.
10. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
11. Li Y, Liu J, Yuan C, Cui B, Zou X, Qiao Y. High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia. J Int Med Res 2011, 38(5):1730-1736.
12. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008, 27(18):2575-2582. 10.1038/sj.onc.1210919, 2447163, 17998940.
13. Marinkovich MP. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 2007, 7(5):370-380. 10.1038/nrc2089, 17457303.
14. Reshmi G, Surya R, Jissa VT, Babu PS, Preethi NR, Santhi WS, Jayaprakash PG, Pillai MR. C-T variant in a miRNA target site of BCL2 is associated with increased risk of human papilloma virus related cervical cancer-an in silico approach. Genomics 2011, 98(3):189-193. 10.1016/j.ygeno.2011.06.005, 21704150.
15. WHO World Health Organization. International histological classification of tumours 2010, Available at http://whoint/classifications/icd/en/., WHO.
16. He J, Qiu LX, Wang MY, Hua RX, Zhang RX, Yu HP, Wang YN, Sun MH, Zhou XY, Yang YJ. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 2012, 131(7):1235-1244. 10.1007/s00439-012-1152-8, 22371296.
17. Shi TY, Zhu ML, He J, Wang MY, Li QX, Zhou XY, Sun MH, Shao ZM, Yu KD, Cheng X. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. Hum Genet 2012,
18. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69(1):138-147. 10.1086/321276, 1226028, 11404819.
19. WHO World Health Organization. Global database on body mass index 2009, Available at http://appswhoint/bmi/indexjsp., WHO.
20. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96(6):434-442. 10.1093/jnci/djh075, 15026468.
21. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006, 66(15):7390-7394. 10.1158/0008-5472.CAN-06-0800, 16885332.
22. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103(24):9136-9141. 10.1073/pnas.0508889103, 1474008, 16754881.
23. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007, 104(9):3300-3305. 10.1073/pnas.0611347104, 1805605, 17360642.
24. Cho WC. Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev Mol Diagn 2010, 10(6):699-703. 10.1586/erm.10.64, 20843192.
25. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34(Database issue):D140-144. 1347474, 16381832.
26. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9(3):189-198. 10.1016/j.ccr.2006.01.025, 16530703.
27. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010, 6(3):e1000879. 10.1371/journal.pgen.1000879, 2837402, 20300657.
28. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011, 71(17):5765-5778. 10.1158/0008-5472.CAN-11-0368, 21795477.
29. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011, 71(6):2381-2391. 10.1158/0008-5472.CAN-10-2754, 21385904.
30. Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, Duhig EE, Passmore LH, Bowman RV, Fong KM. MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 2010, 5(9):e12560. 10.1371/journal.pone.0012560, 2933228, 20838434.
31. Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K, Auer G. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999, 91(21):1882-1887. 10.1093/jnci/91.21.1882, 10547396.
32. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39(10):1278-1284. 10.1038/ng2135, 17893677.
33. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 2010, 26(3):132-141. 10.1016/j.tig.2009.12.008, 2826571, 20106545.
34. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131(10):2349-2359. 10.1002/ijc.27485, 22323075.